Now that much of the political buzz surrounding stem cells has quieted, scientists are left to prove whether or not the technology is successful. At this event, speakers will explore recent advances in the field, intellectual property rights in regenerative medicine, getting the technology from research to market, and the stake big pharma companies have in the matter. Register online.